Unichem Laboratories Ltd. News and Updates

Name: Latest research reports of Unichem Laboratories Ltd. authored by Ashika Research and published by - Trendlyne research reports.
Item: Unichem Laboratories Ltd.
Rating: 5
Author: Ashika Research

Keep track of all breaking news on Unichem Laboratories Ltd. from all sources in a single place.

Load latest

Unichem Laboratories Ltd.

01 Aug 2016

607.00

-0.83%

Unichem Laboratories Ltd.

Buy: Unichem Laboratories Ltd.

Ashika Research

has domestic leadership in niche therapy areas of cardiology, neurology, orthopaedics and anti infective. By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting-edge research in...

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Laboratories Ltd.

26 Jul 2016

607.00

-0.83%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

Target

ICICI Securities Limited

Revenues grew 9.5% YoY to | 342.0 crore (I-direct estimate: | 341.8 crore) on account of 12.5% YoY growth in domestic sales to | 221.5 crore (I-direct estimate: | 204.0 crore) and 16.7% growth in export sales to | 97.1 crore (I-direct estimate: | 104.2 crore). De-growth in APIs growth (-25% YoY), however, pulled down the numbers a bit. EBITDA margins declined 80 bps YoY to 12.9% (I-direct estimate: 10.9%) mainly due to higher employee cost and provision for diminution in the Brazilian subsidiary • Net profit witnessed a YoY decline of 11.1% to | 25.8 crore (I-direct estimate: | 26.1 crore) mainly due to higher taxation. ICICI Securities Limited ascribe a target price of | 340, based on 16x (earlier 14x) FY18E EPS of | 21.1.

Trendlyne has 5 reports on UNICHEMLAB updated in the last year from 2 brokers with an average target of Rs 321.5. Brokers have a rating for UNICHEMLAB with 1 upgrade and 3 price upgrades in past 6 months.

Unichem Laboratories Ltd. has lost -24.61% in the last 6 Months

Unichem Laboratories Ltd.

25 Jul 2016

607.00

-0.83%

Unichem Q1 net dips 11 per cent at Rs 26 crore

Economic Times

Net sales of the firm rose to Rs 334.9 crore as compared to Rs 304.49 crore during the same period of previous fiscal, Unichem Laboratories said in a BSE filing.

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Q1 net down 11% at Rs 26 cr

Business Line | 25 Jul 2016 2 more

Unichem Laboratories Ltd.

24 May 2016

607.00

-0.83%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 17.8% YoY to | 301.5 crore (I-direct estimate: | 311.1 crore) on account of 17.1% YoY growth in domestic sales to | 171.3...

Unichem Laboratories Ltd. has lost -24.61% in the last 6 Months

Unichem Laboratories Ltd.

20 May 2016

607.00

-0.83%

Unichem Laboratories Q4 profit rises threefold to Rs28.15 crore

livemint

Profit of Unichem laboratories increases on account of improved performance of its domestic and international formulations business

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Laboratories Ltd.

09 Mar 2016

607.00

-0.83%

Unichem gains on USFDA nod for Quetiapine Fumarate tablets

Business Standard

Quetiapine Fumarate is an atypical antipsychotic indicated for the treatment of Schizophrenia,

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Laboratories Ltd.

22 Feb 2016

607.00

-0.83%

Unichem Labs: Management Interaction: US business to gain traction (Feb 22, 2016)

Buy: Unichem Laboratories Ltd.

Target

Karvy

Unichem has completed 6 years in US market. The company started launching few products in 2009. The year 2014-2015 (USD 24 mn) saw a near 100% growth on the back new launches.

Unichem Laboratories Ltd. has lost -24.61% in the last 6 Months

Unichem Laboratories Ltd.

29 Jan 2016, 04:59PM

607.00

-0.83%

Unichem Gets US Regulator Nod to Sell Prostate Drug

NDTV Business

Drug firm Unichem Laboratories has received approval from the US health regulator to market alfuzosin hydrochloride extended release tablets, used in treating prostatic hyperlasia, in the American mar...

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Laboratories Ltd.

27 Jan 2016

607.00

-0.83%

Unichem Labs: Q3FY16 Result Review Progress Continues (Jan 27, 2016)

Buy: Unichem Laboratories Ltd.

Recommendation Target

Karvy

Unichem's total revenues increased by 15.2% YoY to Rs 3.06 bn in Q3FY16 higher than our estimates of Rs 2.98 bn while on QoQ basis it increased marginally by 0.2%. Operating margins increased by 790bps YoY to 11.1% (lower than our estimate of 12.3%).